170 related articles for article (PubMed ID: 33720083)
1. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability in uterine sarcomas.
Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
[TBL] [Abstract][Full Text] [Related]
4. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
6. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcomas 2013.
Sutton G
Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
[No Abstract] [Full Text] [Related]
8. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
10. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
[TBL] [Abstract][Full Text] [Related]
12. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
Sangoi AR; Kshirsagar M; Horvai AE; Roma AA
Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605
[TBL] [Abstract][Full Text] [Related]
13. ERBB-2 gene overexpression and amplification in uterine sarcomas.
Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
[TBL] [Abstract][Full Text] [Related]
14. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
15. A case of three rare uterine neoplasms in the same surgical specimen.
Giuliani A; Romano L; Romanzi F; Giubbolini G; Coletti G; Di Stefano N; Le'Clerc JN; Schietroma M; Carlei F; Di Stefano L
Ann Ital Chir; 2020 Jan; 9():. PubMed ID: 32129176
[TBL] [Abstract][Full Text] [Related]
16. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcomas: clinical presentation and MRI features.
Santos P; Cunha TM
Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
[TBL] [Abstract][Full Text] [Related]
19. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
20. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]